Askorel Pediatric Drop 15ml

PRESENTATION

Askorel SR tablet: Each sustained release tablet contains Butamirate Citrate INN 50 mg.

Askorel syrup: Each 5 ml syrup contains Butamirate Citrate INN 7.5 mg.

Askorel paediatric drops: Each ml drop contains Butamirate Citrate INN 5 mg.

DESCRIPTION

Butamirate Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, moderate bronchodilating and

anti-inflammatory action. Butamirate Citrate also increases the spirometery indexes and blood oxygenation. It is safe and

non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. The active metabolites of Butamirate

Citrate have also antitussive action.

INDICATIONS

Askorel is indicated in acute cough of any etiology, suppression of pre-& post-operative cough in surgery & bronchoscopy and

suppression of whooping cough.

DOSAGE & ADMINISTRATION

Dosage formAgeDoseSRTabletAdolescents over 12 years1-2 tablets dailyAdults2-3 tablets daily at 8-12 hoursintervalSyrupInfants (2

months - 1 year)1.5 ml four times dailyInfants (1 - 3 years)2.5 ml four times dailyChildren 3-5 years of age7.5 ml three times

daily> 6 years and adults15 ml three times dailyPaediatricdropsInfants (2 months - 1 year)10 drops four times dailyInfants (1 - 3

years)15 drops four times daily

SIDE EFFECTS

Tolerance of Butamirate Citrate is good. Adverse reactions such as rash, nausea, diarrhea and vertigo have been observed in a few

rare cases, resolving after dose reduction or treatment withdrawal.

PRECAUTIONS

Not applicable

USE IN PREGNANCY & LACTATION

Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used

if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the

active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully

weighed against the risks.

OVER DOSE

Accidental overdose with Butamirate Citrate can cause the following symptoms: drowsiness, nausea, vomiting, diarrhea, loss of

balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard

cardio-respiratory resuscitation.

STORAGE

Do not store above 30 0 C. Keep away from light and out of the reach of children.

COMMERCIAL PACK

Askorel SR tablet: Each box contains 3 Alu-Alu blister strips of 10 tablets.

Askorel syrup: Each box contains 1 PET bottle containing 100 ml Syrup & 20 ml measuring cup. Askorel pediatric drops: Each box

contains 1 amber glass bottle containing 15 ml pediatric drops and one 1.25 ml dropper